Cargando…

Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region

BACKGROUND: There are no studies that measure the prevalence and real comorbidities of neurodevelopmental disorders (NDDs) according to the DSM-5-TR in 6-year-old children in population and clinical samples or studies that measure them as a whole. The data on the prevalence of these disorders are us...

Descripción completa

Detalles Bibliográficos
Autores principales: Francés, Lorena, Ruiz, Antoni, Soler, C. Virgínia, Francés, Joan, Caules, Jessica, Hervás, Amaia, Carretero, Carolina, Cardona, Bárbara, Quezada, Elizabeth, Fernández, Alberto, Quintero, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667691/
https://www.ncbi.nlm.nih.gov/pubmed/38025459
http://dx.doi.org/10.3389/fpsyt.2023.1260747
_version_ 1785139303846772736
author Francés, Lorena
Ruiz, Antoni
Soler, C. Virgínia
Francés, Joan
Caules, Jessica
Hervás, Amaia
Carretero, Carolina
Cardona, Bárbara
Quezada, Elizabeth
Fernández, Alberto
Quintero, Javier
author_facet Francés, Lorena
Ruiz, Antoni
Soler, C. Virgínia
Francés, Joan
Caules, Jessica
Hervás, Amaia
Carretero, Carolina
Cardona, Bárbara
Quezada, Elizabeth
Fernández, Alberto
Quintero, Javier
author_sort Francés, Lorena
collection PubMed
description BACKGROUND: There are no studies that measure the prevalence and real comorbidities of neurodevelopmental disorders (NDDs) according to the DSM-5-TR in 6-year-old children in population and clinical samples or studies that measure them as a whole. The data on the prevalence of these disorders are usually disparate because of the estimation methods (direct/indirect), the type of sample (population/clinical/school), and the ages studied. METHODS: The initial sample (289 subjects) was representative of 6-year-old children in the entire population of Menorca, obtained from pediatric primary care services (100% of the sample). The patients were divided into two groups based on the criterion of verification of clinical warning signs. One of the groups represented the clinical or experimental sample (EG) (81 subjects) at risk of NDDs; the other group was considered the control sample (CG) (210 subjects), and they were subjects without risk of suffering NDDs. A direct clinical assessment of the clinical sample was carried out, and they were administered the Wechsler Intelligence Scale for Children (WISC-V), the Clinical Evaluation of Language Fundamentals (CELF-5), the Battery for the evaluation of the processes of revised reading (Batería para la evaluación de los procesos de lectura revisada – PROLEC-R), the Test for the Diagnosis of Basic Mathematical Competences, (TEDI-MATH), and the Developmental Coordination Disorder Questionnaire (DCDQ). RESULTS: A total of 21.5% of the initial sample suffered from an NDD. A total of 2.4% presented autism spectrum disorder (ASD); 14% presented attention-deficit hyperactivity disorder (ADHD); 0.34% presented mild intellectual disability; 9.54% presented communication disorder (CD) (5.8% language disorder, 3.4% phonological disorder, and 0.34% stuttering); 10% presented learning disorder with reading difficulties; 5.8% presented learning disorder with difficulties in writing; 3.11% presented learning disorder with difficulties in mathematics; 1% presented transitory tic disorder; 0.34% presented chronic tic disorder; 1% presented Tourette syndrome; 2% presented motor coordination disorder (MCD); and 0.34% presented stereotypic movement disorders. Male children were more affected than female children in general, with male/female ORs of 0.14/0.92 for the presence of comorbidities, 0.11/0.88 for combined ADHD, 0.06/0.87 for language disorder, 1.02/1.27 for MCD, and 1.39/1.02 for inattentive ADHD. CONCLUSION: In disadvantaged contexts, there was a higher prevalence of NDDs and comorbidities, unless the disorder was extreme, in which case only the NDD manifestations were presented. A significant proportion of the sample had not been previously diagnosed (88.6%); therefore, early detection programs are recommended to identify warning signs and develop policies that help and support the most disadvantaged sectors of the population.
format Online
Article
Text
id pubmed-10667691
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106676912023-11-10 Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region Francés, Lorena Ruiz, Antoni Soler, C. Virgínia Francés, Joan Caules, Jessica Hervás, Amaia Carretero, Carolina Cardona, Bárbara Quezada, Elizabeth Fernández, Alberto Quintero, Javier Front Psychiatry Psychiatry BACKGROUND: There are no studies that measure the prevalence and real comorbidities of neurodevelopmental disorders (NDDs) according to the DSM-5-TR in 6-year-old children in population and clinical samples or studies that measure them as a whole. The data on the prevalence of these disorders are usually disparate because of the estimation methods (direct/indirect), the type of sample (population/clinical/school), and the ages studied. METHODS: The initial sample (289 subjects) was representative of 6-year-old children in the entire population of Menorca, obtained from pediatric primary care services (100% of the sample). The patients were divided into two groups based on the criterion of verification of clinical warning signs. One of the groups represented the clinical or experimental sample (EG) (81 subjects) at risk of NDDs; the other group was considered the control sample (CG) (210 subjects), and they were subjects without risk of suffering NDDs. A direct clinical assessment of the clinical sample was carried out, and they were administered the Wechsler Intelligence Scale for Children (WISC-V), the Clinical Evaluation of Language Fundamentals (CELF-5), the Battery for the evaluation of the processes of revised reading (Batería para la evaluación de los procesos de lectura revisada – PROLEC-R), the Test for the Diagnosis of Basic Mathematical Competences, (TEDI-MATH), and the Developmental Coordination Disorder Questionnaire (DCDQ). RESULTS: A total of 21.5% of the initial sample suffered from an NDD. A total of 2.4% presented autism spectrum disorder (ASD); 14% presented attention-deficit hyperactivity disorder (ADHD); 0.34% presented mild intellectual disability; 9.54% presented communication disorder (CD) (5.8% language disorder, 3.4% phonological disorder, and 0.34% stuttering); 10% presented learning disorder with reading difficulties; 5.8% presented learning disorder with difficulties in writing; 3.11% presented learning disorder with difficulties in mathematics; 1% presented transitory tic disorder; 0.34% presented chronic tic disorder; 1% presented Tourette syndrome; 2% presented motor coordination disorder (MCD); and 0.34% presented stereotypic movement disorders. Male children were more affected than female children in general, with male/female ORs of 0.14/0.92 for the presence of comorbidities, 0.11/0.88 for combined ADHD, 0.06/0.87 for language disorder, 1.02/1.27 for MCD, and 1.39/1.02 for inattentive ADHD. CONCLUSION: In disadvantaged contexts, there was a higher prevalence of NDDs and comorbidities, unless the disorder was extreme, in which case only the NDD manifestations were presented. A significant proportion of the sample had not been previously diagnosed (88.6%); therefore, early detection programs are recommended to identify warning signs and develop policies that help and support the most disadvantaged sectors of the population. Frontiers Media S.A. 2023-11-10 /pmc/articles/PMC10667691/ /pubmed/38025459 http://dx.doi.org/10.3389/fpsyt.2023.1260747 Text en Copyright © 2023 Francés, Ruiz, Soler, Francés, Caules, Hervás, Carretero, Cardona, Quezada, Fernández and Quintero. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Francés, Lorena
Ruiz, Antoni
Soler, C. Virgínia
Francés, Joan
Caules, Jessica
Hervás, Amaia
Carretero, Carolina
Cardona, Bárbara
Quezada, Elizabeth
Fernández, Alberto
Quintero, Javier
Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region
title Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region
title_full Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region
title_fullStr Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region
title_full_unstemmed Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region
title_short Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region
title_sort prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the dsm-5-tr in children aged 6 years old in a european region
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667691/
https://www.ncbi.nlm.nih.gov/pubmed/38025459
http://dx.doi.org/10.3389/fpsyt.2023.1260747
work_keys_str_mv AT franceslorena prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT ruizantoni prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT solercvirginia prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT francesjoan prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT caulesjessica prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT hervasamaia prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT carreterocarolina prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT cardonabarbara prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT quezadaelizabeth prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT fernandezalberto prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion
AT quinterojavier prevalencecomorbiditiesandprofilesofneurodevelopmentaldisordersaccordingtothedsm5trinchildrenaged6yearsoldinaeuropeanregion